Table 1.
Characteristics of 8987 Hospitalized Patients With Acute HFpEF From the ARIC Community Surveillance Study (2005–2014)
| No. (%), Mean (SD), or Median [IQI] | Unweighted No. (Before Excluding Covariates Missing in the Fully Adjusted Model) | |
|---|---|---|
| N=8987 (weighted)* | 2847 | |
| Age, y | 77.2 (10.4) | 2847 |
| Men, % | 3153 (35.1) | 2847 |
| Black participants, % | 2101 (23.4) | 2847 |
| Admission to teaching hospital, % | 3084 (34.3) | 2847 |
| History of HF hospitalization, % | 2282 (25.4) | 2847 |
| Hypertension, % | 7968 (88.7) | 2847 |
| Diabetes mellitus, % | 4245 (47.2) | 2846 |
| Atrial fibrillation/flutter, % | 3602 (40.1) | 2847 |
| Coronary artery disease, % | 3989 (44.4) | 2591 |
| Pulmonary hypertension, % | 1859 (20.7) | 2845 |
| Sleep apnea, % | 1397 (15.5) | 2847 |
| COPD, % | 3414 (38.0) | 2847 |
| End‐stage renal disease, % | 467 (5.2) | 2847 |
| Heart rate, beats per min | 86.5 (23.6) | 2824 |
| SBP, mm Hg | 146.7 (32.3) | 2813 |
| BMI, kg/m2 | 31.3 (10.8) | 2440 |
| Sodium (worst), mmol/L | 136.1 (4.5) | 2825 |
| eGFR, mL/min per 1.73 m2 | 40.0 (22.3) | 2530 |
| BNP (worst), pg/mL | 550 [285–1041] | 1999 |
| NT‐proBNP (worst), pg/mL | 3640 [1611–8148] | 494 |
| Hemoglobin (last), g/dL | 11.2 (1.9) | 2821 |
ARIC indicates Atherosclerosis Risk in Communities; BMI, body mass index; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; IQI, interquartile interval; and SBP, systolic blood pressure.
*
The available unweighted number of patients was 1892 except for following laboratory results: B‐type natriuretic peptide (BNP; n=1378) and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide; n=298).